Rhinovirus, Coronavirus, Enterovirus, and Bocavirus After Hematopoietic Cell Transplantation or Solid Organ Transplantation

Chapter

Abstract

Respiratory viral infections represent a significant cause of morbidity and mortality in immunocompromised hosts. Newer molecular detection assays have allowed for the characterization of several respiratory viruses not previously recognized as having significant clinical impact in the immunocompromised population. Human rhinoviruses are the most common respiratory viruses detected in the upper respiratory tract of hematopoietic cell transplant and lung transplant recipients, and evidence on the impact on clinical outcomes is mounting. Other respiratory viruses including enteroviruses (EVs), coronaviruses (CoVs), and bocavirus may also contribute to pulmonary disease; however, data is limited in the immunocompromised population. Further studies are needed to define the epidemiology, risk factors, and clinical outcomes of these infections; this data will help inform decisions regarding development of antiviral therapy and infection prevention strategies.

Keywords

Rhinovirus Enterovirus Coronavirus Bocavirus 

References

  1. 1.
    Ljungman P, Ward KN, Crooks BNA, Parker A, Martino R, Shaw PJ, et al. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2001;28(5):479–84.PubMedCrossRefGoogle Scholar
  2. 2.
    Bowden MDRA. Respiratory virus infections after marrow transplant: the Fred Hutchinson cancer research center experience. Am J Med. 1997;102(3):27–30.PubMedCrossRefGoogle Scholar
  3. 3.
    Hassan IA, Chopra R, Swindell R, Mutton KJ. Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie hospital experience. Bone Marrow Transplant. 2003;32(1):73–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Milano F, Campbell AP, Guthrie KA, Kuypers J, Englund JA, Corey L, et al. Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipients. Blood. 2010;115(10):2088–94.PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Kumar D, Erdman D, Keshavjee S, Peret T, Tellier R, Hadjiliadis D, et al. Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant. 2005;5(8):2031–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Soccal PM, Aubert JD, Bridevaux PO, Garbino J, Thomas Y, Rochat T, et al. Upper and lower respiratory tract viral infections and acute graft rejection in lung transplant recipients. Clin Infect Dis. 2010;51(2):163–70.PubMedCrossRefGoogle Scholar
  7. 7.
    Kumar D, Husain S, Chen MH, Moussa G, Himsworth D, Manuel O, et al. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients. Transplantation. 2010;89(8):1028–33.PubMedCrossRefGoogle Scholar
  8. 8.
    Bridevaux PO, Aubert JD, Soccal PM, Mazza-Stalder J, Berutto C, Rochat T, et al. Incidence and outcomes of respiratory viral infections in lung transplant recipients: a prospective study. Thorax. 2014;69(1):32–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Fisher CE, Preiksaitis CM, Lease ED, Edelman J, Kirby KA, Leisenring WM, Boeckh M, Limaye AP. Symptomatic respiratory virus infection and chronic lung allograft dysfunction. Clin Infect Dis. 2016;62(3):313–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Palmenberg AC, Rathe JA, Liggett SB. Analysis of the complete genome sequences of human rhinovirus. J Allergy Clin Immunol. 2010;125(6):1190–9. quiz 200–1.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Vlasak M, Roivainen M, Reithmayer M, Goesler I, Laine P, Snyers L, et al. The minor receptor group of human rhinovirus (HRV) includes HRV23 and HRV25, but the presence of a lysine in the VP1 HI loop is not sufficient for receptor binding. J Virol. 2005;79(12):7389–95.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Bochkov YA, Watters K, Ashraf S, Griggs TF, Devries MK, Jackson DJ, et al. Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication. Proc Natl Acad Sci U S A. 2015;112(17):5485–90.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Bochkov YA, Gern JE. Clinical and molecular features of human rhinovirus C. Microbes Infect. 2012;14(6):485–94.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Ashraf S, Brockman-Schneider R, Bochkov YA, Pasic TR, Gern JE. Biological characteristics and propagation of human rhinovirus-C in differentiated sinus epithelial cells. Virology. 2013;436(1):143–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Arruda E, Pitkaranta A, Witek Jr TJ, Doyle CA, Hayden FG. Frequency and natural history of rhinovirus infections in adults during autumn. J Clin Microbiol. 1997;35(11):2864–8.PubMedPubMedCentralGoogle Scholar
  16. 16.
    Johnston SL. Natural and experimental rhinovirus infections of the lower respiratory tract. Am J Respir Crit Care Med. 1995;152(4 pt 2):S46–52.PubMedCrossRefGoogle Scholar
  17. 17.
    Gern JE, Palmenberg AC. Rhinoviruses. In: Knipe DM, Howley PM, editors. Fields virology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013. p. 531–49.Google Scholar
  18. 18.
    Couch MDRB, Englund MDJA. Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Med. 1997;102(3):2–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Gwaltney J, Rueckert R. Rhinovirus. In: Richman DD, Whitley RJ, Hayden FG, editors. Clinical virology. New York: Churchill Livingstone; 1997. p. 1025–47.Google Scholar
  20. 20.
    Gern JE, Galagan DM, Jarjour NN, Dick EC, Busse WW. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med. 1997;155(3):1159–61.PubMedCrossRefGoogle Scholar
  21. 21.
    Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med. 2015;373(5): 415–27.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Landry M. Rhinoviruses. In: Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW, editors. Manual of clinical microbiology. 10th ed. Washington, DC: ASM Press; 2011. p. 1400–9.Google Scholar
  23. 23.
    Ghosh S, Champlin R, Couch R, Englund J, Malik S. Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients. Clin Infect Dis. 1999;29(3):528–32.PubMedCrossRefGoogle Scholar
  24. 24.
    Gutman JA, Peck AJ, Kuypers J, Boeckh M. Rhinovirus as a cause of fatal lower respiratory tract infection in adult stem cell transplantation patients: a report of two cases. Bone Marrow Transplant. 2007;40(8):809–11.PubMedCrossRefGoogle Scholar
  25. 25.
    Ison MG, Hayden FG, Kaiser L, Corey L, Boeckh M. Rhinovirus infections in hematopoietic stem cell transplant recipients with pneumonia. Clin Infect Dis. 2003;36(9):1139–43.PubMedCrossRefGoogle Scholar
  26. 26.
    Jacobs SE, Soave R, Shore TB, Satlin MJ, Schuetz AN, Magro C, et al. Human rhinovirus infections of the lower respiratory tract in hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2013;15(5):474–86.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Papadopoulos Nikolaos G, Bates Philip J, Bardin Philip G, Papi A, Leir Shih H, Fraenkel David J, et al. Rhinoviruses infect the lower airways. J Infect Dis. 2000;181(6):1875–84.CrossRefGoogle Scholar
  28. 28.
    Jacobs SE, Lamson DM, Soave R, Guzman BH, Shore TB, Ritchie EK, et al. Clinical and molecular epidemiology of human rhinovirus infections in patients with hematologic malignancy. J Clin Virol. 2015;71:51–8.PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Kraft CS, Jacob JT, Sears MH, Burd EM, Caliendo AM, Lyon GM. Severity of human rhinovirus infection in immunocompromised adults is similar to that of 2009 H1N1 influenza. J Clin Microbiol. 2012;50(3):1061–3.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Seo S, Martin E, Xie H, Kuypers J, Campbell AP, Choi S, Waghmare A, Leisenring W, Jerome K, Englund J, Boeckh. Human Rhinovirus RNA Detection in the Lower Respiratory Tract of Hematopoietic Cell Transplant recipients: Association with Mortality. Abstract presented at: ASBMT Tandem Meeting; 2013;13–17; Salt Lake City, UT.Google Scholar
  31. 31.
    Fuji N, Suzuki A, Lupisan S, Sombrero L, Galang H, Kamigaki T, et al. Detection of human rhinovirus C viral genome in blood among children with severe respiratory infections in the Philippines. PLoS One. 2011;6(11):e27247.PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    Martin EK, Kuypers J, Chu HY, Lacombe K, Qin X, Strelitz B, et al. Molecular epidemiology of human rhinovirus infections in the pediatric emergency department. J Clin Virol. 2015;62:25–31.PubMedCrossRefGoogle Scholar
  33. 33.
    Bizzintino J, Lee WM, Laing IA, Vang F, Pappas T, Zhang G, et al. Association between human rhinovirus C and severity of acute asthma in children. Eur Respir J. 2011;37(5):1037–42.PubMedCrossRefGoogle Scholar
  34. 34.
    Takeyama A, Hashimoto K, Sato M, Sato T, Kanno S, Takano K, et al. Rhinovirus load and disease severity in children with lower respiratory tract infections. J Med Virol. 2012;84(7):1135–42.PubMedCrossRefGoogle Scholar
  35. 35.
    Launes C, Armero G, Anton A, Hernandez L, Gimferrer L, Cisneros C, et al. Molecular epidemiology of severe respiratory disease by human rhinoviruses and enteroviruses at a tertiary paediatric hospital in Barcelona, Spain. Clin Microbiol Infect. 2015;21(8):799.e5–7.Google Scholar
  36. 36.
    Ferguson PE, Gilroy NM, Faux CE, Mackay IM, Sloots TP, Nissen MD, et al. Human rhinovirus C in adult haematopoietic stem cell transplant recipients with respiratory illness. J Clin Virol. 2013;56(3):255–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Peck AJ, Corey L, Boeckh M. Pretransplantation respiratory syncytial virus infection: impact of a strategy to delay transplantation. Clin Infect Dis. 2004;39(5):673–80.PubMedCrossRefGoogle Scholar
  38. 38.
    Ljungman P, Gleaves CA, Meyers JD. Respiratory virus infection in immunocompromised patients. Bone Marrow Transplant. 1989;4(1):35–40.PubMedGoogle Scholar
  39. 39.
    Bredius RG, Templeton KE, Scheltinga SA, Claas EC, Kroes AC, Vossen JM. Prospective study of respiratory viral infections in pediatric hemopoietic stem cell transplantation patients. Pediatr Infect Dis J. 2004;23(6):518–22.PubMedCrossRefGoogle Scholar
  40. 40.
    Templeton KE, Bredius RG, Scheltinga SA, Claas EC, Vossen JM, Kroes AC. Parainfluenza virus 3 infection pre- and post-haematopoietic stem cell transplantation: re-infection or persistence? J Clin Virol. 2004;29(4):320–2.PubMedCrossRefGoogle Scholar
  41. 41.
    Campbell AP, Guthrie KA, Englund JA, Farney RM, Minerich EL, Kuypers J, et al. Clinical outcomes associated with respiratory virus detection before allogeneic hematopoietic stem cell transplant. Clin Infect Dis. 2015;61(2):192–202.PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Vu DL, Bridevaux PO, Aubert JD, Soccal PM, Kaiser L. Respiratory viruses in lung transplant recipients: a critical review and pooled analysis of clinical studies. Am J Transplant. 2011;11(5):1071–8.PubMedCrossRefGoogle Scholar
  43. 43.
    Ambrosioni J, Bridevaux PO, Aubert JD, Soccal P, Wagner G, Kaiser L. Role of rhinovirus load in the upper respiratory tract and severity of symptoms in lung transplant recipients. J Clin Virol. 2015;64:1–5.PubMedCrossRefGoogle Scholar
  44. 44.
    Johnston SL, Sanderson G, Pattemore PK, Smith S, Bardin PG, Bruce CB, et al. Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol. 1993;31(1):111–7.PubMedPubMedCentralGoogle Scholar
  45. 45.
    Atmar RL, Georghiou PR. Classification of respiratory tract picornavirus isolates as enteroviruses or rhinoviruses by using reverse transcription-polymerase chain reaction. J Clin Microbiol. 1993;31(9):2544–6.PubMedPubMedCentralGoogle Scholar
  46. 46.
    Torgersen H, Skern T, Blaas D. Typing of human rhinoviruses based on sequence variations in the 5′ non-coding region. J Gen Virol. 1989;70(11):3111–6.PubMedCrossRefGoogle Scholar
  47. 47.
    Lu X, Holloway B, Dare RK, Kuypers J, Yagi S, Williams JV, et al. Real-time reverse transcription-PCR assay for comprehensive detection of human rhinoviruses. J Clin Microbiol. 2007;46(2):533–9.PubMedPubMedCentralCrossRefGoogle Scholar
  48. 48.
    Rollinger JM, Schmidtke M. The human rhinovirus: human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery. Med Res Rev. 2011;31(1):42–92.PubMedCrossRefGoogle Scholar
  49. 49.
    Thibaut HJ, Lacroix C, De Palma AM, Franco D, Decramer M, Neyts J. Toward antiviral therapy/prophylaxis for rhinovirus-induced exacerbations of chronic obstructive pulmonary disease: challenges, opportunities, and strategies. Rev Med Virol. 2015. doi: 10.1002/rmv.1856 [Epub ahead of print].
  50. 50.
    Hammond C, Kurten M, Kennedy JL. Rhinovirus and asthma: a storied history of incompatibility. Curr Allergy Asthma Rep. 2015;15(2):502.PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    McIntosh K. Coronaviruses. In: Richman D, Whitley RJ, Hayden FG, editors. Clinical virology. New York: Churchill Livingstone; 1997. p. 1123–32.Google Scholar
  52. 52.
    van der Hoek L, Pyrc K, Jebbink MF, Vermeulen-Oost W, Berkhout RJM, Wolthers KC, et al. Identification of a new human coronavirus. Nat Med. 2004;10(4):368–73.PubMedCrossRefGoogle Scholar
  53. 53.
    Woo PC, Lau SK, Chu CM, Chan KH, Tsoi HW, Huang Y, et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol. 2004;79(2):884–95.CrossRefGoogle Scholar
  54. 54.
    Kuypers J, Martin ET, Heugel J, Wright N, Morrow R, Englund JA. Clinical disease in children associated with newly described coronavirus subtypes. Pediatrics. 2007;119(1):e70–6.PubMedCrossRefGoogle Scholar
  55. 55.
    Heugel J, Martin ET, Kuypers J, Englund JA. Coronavirus-associated pneumonia in previously healthy children. Pediatr Infect Dis J. 2007;26(8):753–5.PubMedCrossRefGoogle Scholar
  56. 56.
    Lee J, Storch GA. Characterization of human coronavirus OC43 and human coronavirus NL63 infections among hospitalized children <5 years of age. Pediatr Infect Dis J. 2014;33(8):814–20.PubMedCrossRefGoogle Scholar
  57. 57.
    Shi Z, Hu Z. A review of studies on animal reservoirs of the SARS coronavirus. Virus Res. 2008;133(1):74–87.PubMedCrossRefGoogle Scholar
  58. 58.
    Liang WN, Zhao T, Liu ZJ, Guan BY, He X, Liu M, et al. Severe acute respiratory syndrome—retrospect and lessons of 2004 outbreak in China. Biomed Environ Sci. 2006;19(6):445–51.PubMedGoogle Scholar
  59. 59.
    Rha B, Rudd J, Feikin D, Watson J, Curns AT, Swerdlow DL, et al. Update on the epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) infection, and guidance for the public, clinicians, and public health authorities. MMWR Morb Mortal Wkly Rep. 2015;64(3):61–2.PubMedGoogle Scholar
  60. 60.
    Majumder MS, Rivers C, Lofgren E, Fisman D. Estimation of MERS-coronavirus reproductive number and case fatality rate for the Spring 2014 Saudi Arabia outbreak: insights from publicly available data. PLoS Curr. 2014;6.Google Scholar
  61. 61.
    Memish ZA, Al-Tawfiq JA, Assiri A, AlRabiah FA, Al Hajjar S, Albarrak A, et al. Middle east respiratory syndrome coronavirus disease in children. Pediatr Infect Dis J. 2014;33(9): 904–6.PubMedCrossRefGoogle Scholar
  62. 62.
    Kumar D, Tellier R, Draker R, Levy G, Humar A. Severe Acute Respiratory Syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening. Am J Transplant. 2003;3(8):977–81.PubMedCrossRefGoogle Scholar
  63. 63.
    Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348(20):1986–94.PubMedCrossRefGoogle Scholar
  64. 64.
    Guery B, Poissy J, el Mansouf L, Sejourne C, Ettahar N, Lemaire X, et al. Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet. 2013;381(9885):2265–72.PubMedCrossRefGoogle Scholar
  65. 65.
    AlGhamdi M, Mushtaq F, Awn N, Shalhoub S. MERS CoV infection in two renal transplant recipients: case report. Am J Transplant. 2015;15(4):1101–4.PubMedCrossRefGoogle Scholar
  66. 66.
    Oosterhof L, Christensen CB, Sengelov H. Fatal lower respiratory tract disease with human corona virus NL63 in an adult haematopoietic cell transplant recipient. Bone Marrow Transplant. 2010;45(6):1115–6.PubMedCrossRefGoogle Scholar
  67. 67.
    Pene F, Merlat A, Vabret A, Rozenberg F, Buzyn A, Dreyfus F, et al. Coronavirus 229E-related pneumonia in immunocompromised patients. Clin Infect Dis. 2003;37(7):929–32.PubMedCrossRefGoogle Scholar
  68. 68.
    Simon A, Volz S, Fleischhack G, Tillman R, Muller A, Bode U, et al. Human coronavirus OC43 pneumonia in a pediatric cancer patient with Down syndrome and acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2007;29(6):432–4.PubMedCrossRefGoogle Scholar
  69. 69.
    Gerna G, Campanini G, Rovida F, Percivalle E, Sarasini A, Marchi A, et al. Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients. J Med Virol. 2006;78(7): 938–49.PubMedCrossRefGoogle Scholar
  70. 70.
    Folz RJ, Elkordy MA. Coronavirus pneumonia following autologous bone marrow transplantation for breast cancer. Chest. 1999;115(3):901–5.PubMedCrossRefGoogle Scholar
  71. 71.
    Uhlenhaut C, Cohen JI, Pavletic S, Illei G, Gea-Banacloche JC, Abu-Asab M, et al. Use of a novel virus detection assay to identify coronavirus HKU1 in the lungs of a hematopoietic stem cell transplant recipient with fatal pneumonia. Transpl Infect Dis. 2012;14(1):79–85.PubMedCrossRefGoogle Scholar
  72. 72.
    Gomersall CD, Joynt GM, Lam P, Li T, Yap F, Lam D, et al. Short-term outcome of critically ill patients with severe acute respiratory syndrome. Intensive Care Med. 2004;30(3):381–7.PubMedCrossRefGoogle Scholar
  73. 73.
    Monto AS. Coronaviruses. Viral infections of humans. New York: Springer; 1997. p. 211–27.CrossRefGoogle Scholar
  74. 74.
    World Health Organization. Laboratory testing for Middle East respiratory syndrome coronavirus 2015. Available from: http://www.who.int/csr/disease/coronavirus_infections/mers-laboratory-testing/en/.
  75. 75.
    Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006;3(9):e343.PubMedPubMedCentralCrossRefGoogle Scholar
  76. 76.
    Omrani AS, Saad MM, Baig K, Bahloul A, Abdul-Matin M, Alaidaroos AY, et al. Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis. 2014;14(11):1090–5.PubMedCrossRefGoogle Scholar
  77. 77.
    Al-Tawfiq JA, Momattin H, Dib J, Memish ZA. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study. Int J Infect Dis. 2014;20:42–6.PubMedCrossRefGoogle Scholar
  78. 78.
    Schieble JH, Fox VL, Lennette EH. A probable new human picornavirus associated with respiratory diseases. Am J Epidemiol. 1967;85(2):297–310.PubMedCrossRefGoogle Scholar
  79. 79.
    Centers for Disease Control and Prevention. Clusters of acute respiratory illness associated with human enterovirus 68—Asia, Europe, and United States, 2008–2010. MMWR Morb Mortal Wkly Rep. 2011;60(38):1301–4.Google Scholar
  80. 80.
    Imamura T, Fuji N, Suzuki A, Tamaki R, Saito M, Aniceto R, et al. Enterovirus 68 among children with severe acute respiratory infection, the Philippines. Emerg Infect Dis. 2011;17(8):1430–5.PubMedPubMedCentralGoogle Scholar
  81. 81.
    Imamura T, Suzuki A, Lupisan S, Kamigaki T, Okamoto M, Roy CN, et al. Detection of enterovirus 68 in serum from pediatric patients with pneumonia and their clinical outcomes. Influenza Other Respi Viruses. 2014;8(1):21–4.CrossRefGoogle Scholar
  82. 82.
    Kaida A, Kubo H, Sekiguchi J, Kohdera U, Togawa M, Shiomi M, et al. Enterovirus 68 in children with acute respiratory tract infections, Osaka, Japan. Emerg Infect Dis. 2011;17(8):1494–7.PubMedPubMedCentralGoogle Scholar
  83. 83.
    Wang YC, Cheng HB, Chen HH, Liu CM, Chou CH, Sung FC. Circulating viruses associated with severe complicated enterovirus infection in Taiwan: a multi-year analysis. Pediatr Infect Dis J. 2010;29(4):334–9.PubMedGoogle Scholar
  84. 84.
    Kreuter JD, Barnes A, McCarthy JE, Schwartzman JD, Oberste MS, Rhodes CH, et al. A fatal central nervous system enterovirus 68 infection. Arch Pathol Lab Med. 2011;135(6):793–6.PubMedGoogle Scholar
  85. 85.
    Midgley CM, Jackson MA, Selvarangan R, Turabelidze G, Obringer E, Johnson D, et al. Severe respiratory illness associated with enterovirus D68—Missouri and Illinois, 2014. MMWR Morb Mortal Wkly Rep. 2014;63(36):798–9.PubMedGoogle Scholar
  86. 86.
    Bragstad K, Jakobsen K, Rojahn AE, Skram MK, Vainio K, Holberg-Petersen M, et al. High frequency of enterovirus D68 in children hospitalised with respiratory illness in Norway, autumn 2014. Influenza Other Respi Viruses. 2015;9(2):59–63.CrossRefGoogle Scholar
  87. 87.
    Poelman R, Scholvinck EH, Borger R, Niesters HG, van Leer-Buter C. The emergence of enterovirus D68 in a Dutch University Medical Center and the necessity for routinely screening for respiratory viruses. J Clin Virol. 2015;62:1–5.PubMedCrossRefGoogle Scholar
  88. 88.
    Furuse Y, Chaimongkol N, Okamoto M, Imamura T, Saito M, Tamaki R, et al. Molecular epidemiology of enterovirus d68 from 2013 to 2014 in Philippines. J Clin Microbiol. 2015;53(3):1015–8.PubMedPubMedCentralCrossRefGoogle Scholar
  89. 89.
    Drews SJ, Simmonds K, Usman HR, Yee K, Fathima S, Tipples G, et al. Characterization of enterovirus activity, including that of enterovirus D68, in pediatric patients in Alberta, Canada, in 2014. J Clin Microbiol. 2015;53(3):1042–5.PubMedPubMedCentralCrossRefGoogle Scholar
  90. 90.
    Vongpunsawad S, Prachayangprecha S, Chansaenroj J, Haagmans BL, Smits SL, Poovorawan Y. Genome sequence of enterovirus D68 and clinical disease, Thailand. Emerg Infect Dis. 2015;21(2):384.PubMedPubMedCentralCrossRefGoogle Scholar
  91. 91.
    Pfeiffer HC, Bragstad K, Skram MK, Dahl H, Knudsen PK, Chawla MS, et al. Two cases of acute severe flaccid myelitis associated with enterovirus D68 infection in children, Norway, autumn 2014. Euro Surveill. 2015;20(10):21062.PubMedCrossRefGoogle Scholar
  92. 92.
    Torres JP, Farfan MJ, Izquierdo G, Piemonte P, Henriquez J, O'Ryan ML. Enterovirus D68 infection, Chile, Spring 2014. Emerg Infect Dis. 2015;21(4):728–9.PubMedPubMedCentralCrossRefGoogle Scholar
  93. 93.
    Reiche J, Bottcher S, Diedrich S, Buchholz U, Buda S, Haas W, et al. Low-level circulation of enterovirus D68-associated acute respiratory infections, Germany, 2014. Emerg Infect Dis. 2015;21(5):837–41.PubMedPubMedCentralCrossRefGoogle Scholar
  94. 94.
    Midgley SE, Christiansen CB, Poulsen MW, Hansen CH, Fischer TK. Emergence of enterovirus D68 in Denmark, June 2014 to February 2015. Euro Surveill. 2015;20(17).Google Scholar
  95. 95.
    Roda D, Perez-Martinez E, Cabrerizo M, Trallero G, Martinez-Planas A, Luaces C, et al. Clinical characteristics and molecular epidemiology of Enterovirus infection in infants <3 months in a referral paediatric hospital of Barcelona. Eur J Pediatr. 2015;174:1549–53.PubMedCrossRefGoogle Scholar
  96. 96.
    Bal A, Schuffenecker I, Casalegno JS, Josset L, Valette M, Armand N, et al. Enterovirus D68 nosocomial outbreak in elderly people, France, 2014. Clin Microbiol Infect. 2015;21:e61–2.PubMedCrossRefGoogle Scholar
  97. 97.
    Parody R, Rabella N, Martino R, Otegui M, del Cuerpo M, Coll P, et al. Upper and lower respiratory tract infections by human enterovirus and rhinovirus in adult patients with hematological malignancies. Am J Hematol. 2007;82(9):807–11.PubMedCrossRefGoogle Scholar
  98. 98.
    Greninger AL, Naccache SN, Messacar K, Clayton A, Yu G, Somasekar S, et al. A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012–14): a retrospective cohort study. Lancet Infect Dis. 2015;15(6):671–82.PubMedCrossRefGoogle Scholar
  99. 99.
    Messacar K, Schreiner TL, Maloney JA, Wallace A, Ludke J, Oberste MS, et al. A cluster of acute flaccid paralysis and cranial nerve dysfunction temporally associated with an outbreak of enterovirus D68 in children in Colorado, USA. Lancet. 2015;385(9978):1662–71.PubMedCrossRefGoogle Scholar
  100. 100.
    Waghmare A, Pergam SA, Jerome KR, Englund JA, Boeckh M, Kuypers J. Clinical disease due to enterovirus D68 in adult hematologic malignancy patients and hematopoietic cell transplant recipients. Blood. 2015;125(11):1724–9.PubMedPubMedCentralCrossRefGoogle Scholar
  101. 101.
    Centers for Disease Control. Enterovirus D68 (EV-D68) 2014 outbreak strain-specific real-time reverse transcription/polymerase chain reaction (rRT-PCR) assay instructions, Atlanta, GA, 2014. p. 1–13.Google Scholar
  102. 102.
    Abzug MJ, Keyserling HL, Lee ML, Levin MJ, Rotbart HA. Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin. Clin Infect Dis. 1995;20(5):1201–6.PubMedCrossRefGoogle Scholar
  103. 103.
    Yen MH, Huang YC, Chen MC, Liu CC, Chiu NC, Lien R, et al. Effect of intravenous immunoglobulin for neonates with severe enteroviral infections with emphasis on the timing of administration. J Clin Virol. 2015;64:92–6.PubMedCrossRefGoogle Scholar
  104. 104.
    Desmond RA, Accortt NA, Talley L, Villano SA, Soong SJ, Whitley RJ. Enteroviral meningitis: natural history and outcome of pleconaril therapy. Antimicrob Agents Chemother. 2006;50(7):2409–14.PubMedPubMedCentralCrossRefGoogle Scholar
  105. 105.
    Hayden FG, Coats T, Kim K, Hassman HA, Blatter MM, Zhang B, et al. Oral pleconaril treatment of picornavirus-associated viral respiratory illness in adults: efficacy and tolerability in phase II clinical trials. Antivir Ther. 2002;7(1):53–65.PubMedGoogle Scholar
  106. 106.
    Hayden FG, Herrington DT, Coats TL, Kim K, Cooper EC, Villano SA, et al. Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials. Clin Infect Dis. 2003;36(12):1523–32.PubMedCrossRefGoogle Scholar
  107. 107.
    Pevear DC, Hayden FG, Demenczuk TM, Barone LR, McKinlay MA, Collett MS. Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinoviruses. Antimicrob Agents Chemother. 2005;49(11):4492–9.PubMedPubMedCentralCrossRefGoogle Scholar
  108. 108.
    Abzug MJ, Michaels MG, Wald E, Jacobs RF, Romero JR, Sanchez PJ, et al. A randomized, double-blind, placebo-controlled trial of pleconaril for the treatment of neonates with enterovirus sepsis. J Pediatric Infect Dis Soc. 2016;5(1):53–62.PubMedCrossRefGoogle Scholar
  109. 109.
    van der Linden L, Wolthers KC, van Kuppeveld FJ. Replication and inhibitors of enteroviruses and parechoviruses. Viruses. 2015;7(8):4529–62.PubMedPubMedCentralCrossRefGoogle Scholar
  110. 110.
    Allander T, Tammi MT, Eriksson M, Bjerkner A, Tiveljung-Lindell A, Andersson B. From the cover: Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci U S A. 2005;102(36):12891–6.PubMedPubMedCentralCrossRefGoogle Scholar
  111. 111.
    Bastien N, Brandt K, Dust K, Ward D, Li Y. Human bocavirus infection, Canada. Emerg Infect Dis. 2006;12(5):848–50.PubMedPubMedCentralCrossRefGoogle Scholar
  112. 112.
    Martin ET, Fairchok MP, Kuypers J, Magaret A, Zerr DM, Wald A, et al. Frequent and prolonged shedding of bocavirus in young children attending daycare. J Infect Dis. 2010;201(11):1625–32.PubMedPubMedCentralCrossRefGoogle Scholar
  113. 113.
    Martin ET, Kuypers J, McRoberts JP, Englund JA, Zerr DM. Human bocavirus 1 primary infection and shedding in infants. J Infect Dis. 2015;212:516–24.PubMedPubMedCentralCrossRefGoogle Scholar
  114. 114.
    Schenk T, Strahm B, Kontny U, Hufnagel M, Neumann-Haefelin D, Falcone V. Disseminated bocavirus infection after stem cell transplant. Emerg Infect Dis. 2007;13(9):1425–7.PubMedPubMedCentralCrossRefGoogle Scholar
  115. 115.
    Schenk T, Maier B, Hufnagel M, Strahm B, Kontny U, Neumann-Haefelin D, et al. Persistence of human bocavirus DNA in immunocompromised children. Pediatr Infect Dis J. 2011;30(1):82–4.PubMedCrossRefGoogle Scholar
  116. 116.
    Waggoner J, Deresinski S. Rare and emerging viral infection in the transplant population. In: Safdar A, editor. Principles and practice of transplant infectious diseases. Berlin: Springer Medizin; 2013.Google Scholar
  117. 117.
    Schildgen O, Muller A, Allander T, Mackay IM, Volz S, Kupfer B, et al. Human bocavirus: passenger or pathogen in acute respiratory tract infections? Clin Microbiol Rev. 2008;21(2):291–304. table of contents.PubMedPubMedCentralCrossRefGoogle Scholar
  118. 118.
    Miyakis S, van Hal SJ, Barratt J, Stark D, Marriott D, Harkness J. Absence of human Bocavirus in bronchoalveolar lavage fluid of lung transplant patients. J Clin Virol. 2009;44(2):179–80.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Department of PediatricsUniversity of WashingtonSeattleUSA
  2. 2.Vaccine and Infectious Diseases DivisionFred Hutchinson Cancer Research CenterSeattleUSA
  3. 3.Seattle Children’s HospitalSeattleUSA

Personalised recommendations